{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:42:16Z","timestamp":1792741336592,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.cmi.2025.03.018","type":"journal-article","created":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T03:25:41Z","timestamp":1743305141000},"page":"1539-1545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Long-term follow-up of individuals with Chagas disease treated with posaconazole and benznidazole in a non-endemic region: the CHAGASAZOL cohort"],"prefix":"10.1016","volume":"31","author":[{"given":"Joan","family":"Roig-Sanchis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pau","family":"Bosch-Nicolau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aroa","family":"Silgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Salvador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e1n","family":"S\u00e1nchez-Montalv\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Aznar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e9s","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Espinosa-Pereiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00faria","family":"Serre-Delcor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Pou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Mart\u00ednez-Campreci\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Sulleiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.cmi.2025.03.018_bib1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1590\/S0074-02762007000900018","article-title":"Chagas disease: what is known and what is needed\u2014a background article","volume":"102","author":"Coura","year":"2007","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.cmi.2025.03.018_bib2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(17)31612-4","article-title":"Chagas disease","volume":"391","author":"P\u00e9rez-Molina","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2025.03.018_bib3","doi-asserted-by":"crossref","first-page":"6125","DOI":"10.1128\/AAC.04660-14","article-title":"Toxic profile of benznidazole in patients with chronic chagas disease: risk factors and comparison of the product from two different manufacturers","volume":"59","author":"Molina","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2025.03.018_bib4","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa1313122","article-title":"Randomized trial of posaconazole and benznidazole for chronic Chagas\u2019 disease","volume":"370","author":"Molina","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2025.03.018_bib5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1473-3099(17)30538-8","article-title":"Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial","volume":"18","author":"Torrico","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2025.03.018_bib6","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S1473-3099(20)30844-6","article-title":"New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial","volume":"21","author":"Torrico","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2025.03.018_bib7","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jacc.2016.12.023","article-title":"Benznidazole and posaconazole in eliminating parasites in asymptomatic T. Cruzi carriers: the STOP-CHAGAS Trial","volume":"69","author":"Morillo","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cmi.2025.03.018_bib8","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.eimc.2020.01.003","article-title":"Contributions of molecular techniques in the chronic phase of Chagas disease in the absence of treatment","volume":"38","author":"Sulleiro","year":"2020","journal-title":"Enferm Infecc Microbiol Clin (Engl Ed"},{"key":"10.1016\/j.cmi.2025.03.018_bib9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13071-015-0770-0","article-title":"Usefulness of real time PCR to quantify parasite load in serum samples from chronic Chagas disease patients","volume":"8","author":"Melo","year":"2015","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.cmi.2025.03.018_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.787214","article-title":"Association between Trypanosoma cruzi DNA in peripheral blood and chronic chagasic cardiomyopathy: a systematic review","volume":"8","author":"Bosch-Nicolau","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.cmi.2025.03.018_bib11","first-page":"249","article-title":"Evaluation of cardiac function by radioisotopic angiography, in patients with chronic Chagas cardiopathy","volume":"45","author":"Kuschnir","year":"1985","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.cmi.2025.03.018_bib12","doi-asserted-by":"crossref","DOI":"10.1590\/0037-8682-0506-2023","article-title":"Exploring the historical background and clinical implications of electrocardiogram in the context of chagas disease research","volume":"56","author":"Hasslocher-Moreno","year":"2023","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.cmi.2025.03.018_bib13","first-page":"247","article-title":"Clinical and radiological aspects of aperistalsis of the esophagus","volume":"12","author":"de Rezende","year":"1960","journal-title":"Rev Bras Gastroenterol"},{"key":"10.1016\/j.cmi.2025.03.018_bib14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.actatropica.2007.05.019","article-title":"Development of a real-time PCR assay for Trypanosoma cruzi detection in blood samples","volume":"103","author":"Piron","year":"2007","journal-title":"Acta Trop"},{"key":"10.1016\/j.cmi.2025.03.018_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009528","article-title":"Risk of Trypanosoma cruzi infection among travellers visiting friends and relatives to continental Latin America","volume":"15","author":"S\u00e1nchez-Montalv\u00e1","year":"2021","journal-title":"PLOS Negl Trop Dis"},{"key":"10.1016\/j.cmi.2025.03.018_bib16","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.34039","article-title":"Spontaneous dormancy protects Trypanosoma cruzi during extended drug exposure","volume":"7","author":"S\u00e1nchez-Vald\u00e9z","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.cmi.2025.03.018_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011627","article-title":"Benznidazole treatment leads to DNA damage in Trypanosoma cruzi and the persistence of rare widely dispersed non-replicative amastigotes in mice","volume":"19","author":"Jayawardhana","year":"2023","journal-title":"PLOS Pathog"},{"key":"10.1016\/j.cmi.2025.03.018_bib18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/pathogens8040197","article-title":"In vitro benznidazole and nifurtimox susceptibility profile of Trypanosoma cruzi strains belonging to discrete typing units TcI, TcII, and TcV","volume":"8","author":"Revollo","year":"2019","journal-title":"Pathogens"},{"key":"10.1016\/j.cmi.2025.03.018_bib19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1590\/S0074-02761993000100023","article-title":"An experimental and clinical assay with ketoconazole in the treatment of Chagas disease","volume":"88","author":"Brener","year":"1993","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.cmi.2025.03.018_bib20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1051\/parasite\/1997043259","article-title":"Effect of itraconazole on lytic antibodies levels in chronic Chagas disease","volume":"4","author":"Venegas","year":"1997","journal-title":"Parasite"},{"key":"10.1016\/j.cmi.2025.03.018_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0008726","article-title":"Long term follow-up of Trypanosoma cruzi infection and Chagas disease manifestations in mice treated with benznidazole or posaconazole","volume":"14","author":"Calvet","year":"2020","journal-title":"PLOS Negl Trop Dis"},{"key":"10.1016\/j.cmi.2025.03.018_bib22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/QCO.0000000000000192","article-title":"The use of posaconazole against Chagas disease","volume":"28","author":"Molina","year":"2015","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.cmi.2025.03.018_bib23","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1111\/j.1469-0691.2010.03423.x","article-title":"Chagas disease in Latin American migrants: a Spanish challenge","volume":"17","author":"P\u00e9rez-Ayala","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2025.03.018_bib24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1161\/CIRCHEARTFAILURE.108.822627","article-title":"Prevalence of left ventricular diastolic dysfunction in a general population","volume":"2","author":"Kuznetsova","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cmi.2025.03.018_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011330","article-title":"Characterization of Latin American migrants at risk for Trypanosoma cruzi infection in a non-endemic setting. Insights into initial evaluation of cardiac and digestive involvement","volume":"17","author":"Laynez-Rold\u00e1n","year":"2023","journal-title":"PLOS Negl Trop Dis"},{"key":"10.1016\/j.cmi.2025.03.018_bib26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5334\/gh.1207","article-title":"WHF recommendations for the use of echocardiography in CHagas disease","volume":"18","author":"Ralston","year":"2023","journal-title":"Glob Heart"},{"key":"10.1016\/j.cmi.2025.03.018_bib27","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1161\/CIRCULATIONAHA.112.123612","article-title":"Ten-year incidence of Chagas cardiomyopathy among asymptomatic Trypanosoma cruzi-seropositive former blood donors","volume":"127","author":"Sabino","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.cmi.2025.03.018_bib28","doi-asserted-by":"crossref","first-page":"724","DOI":"10.7326\/0003-4819-144-10-200605160-00006","article-title":"Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial","volume":"144","author":"Viotti","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2025.03.018_bib29","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1161\/CIRCRESAHA.124.324507","article-title":"Arrhythmogenic manifestations of Chagas disease: perspectives from the bench to bedside","volume":"134","author":"Roman-Campos","year":"2024","journal-title":"Circ Res"},{"key":"10.1016\/j.cmi.2025.03.018_bib30","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1128\/AAC.02123-15","article-title":"Combination chemotherapy with suboptimal doses of benznidazole and pentoxifylline sustains partial reversion of experimental Chagas\u2019 heart disease","volume":"60","author":"Vilar-Pereira","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2025.03.018_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.1075717","article-title":"Trypanosoma cruzi-specific CD8+ T cells and other immunological hallmarks in chronic Chagas cardiomyopathy: two decades of research","volume":"12","author":"Puerta","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.cmi.2025.03.018_bib32","doi-asserted-by":"crossref","first-page":"7424","DOI":"10.1038\/s41598-023-34572-3","article-title":"Characterizing non-communicable disease trends in undocumented migrants over a period of 10 years in Italy","volume":"13","author":"Fiorini","year":"2023","journal-title":"Sci Rep"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X25001375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X25001375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:22:51Z","timestamp":1788225771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X25001375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1198743X25001375"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2025.03.018","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term follow-up of individuals with Chagas disease treated with posaconazole and benznidazole in a non-endemic region: the CHAGASAZOL cohort","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2025.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2025.06.024","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}